MUC1 and pulmonary fibrosis: Unlike conventional biomarkers of IPF, such as Krebs von den Lungen-6 (KL-6) [8,9,10,11,12,13] and matrix metalloproteases, EVs and miRNAs may be quite specific for cell conditions in pulmonary fibrosis.